9 medicines held by Immedica Pharma AB on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Ammonaps 500 mg Tablets EU/1/99/120/001 |
Sodium phenylbutyrate | Immedica Pharma AB | — |
| Ammonaps 500 mg Tablets EU/1/99/120/002 |
Sodium phenylbutyrate | Immedica Pharma AB | — |
| Ammonaps 940 mg/g Granules EU/1/99/120/003 |
Sodium phenylbutyrate | Immedica Pharma AB | — |
| Ammonaps 940 mg/g Granules EU/1/99/120/004 |
Sodium phenylbutyrate | Immedica Pharma AB | — |
| EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/001 |
Emedastine difumarate | Immedica Pharma AB | — |
| EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/003 |
Emedastine difumarate | Immedica Pharma AB | — |
| EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/004 |
Emedastine difumarate | Immedica Pharma AB | — |
| Loargys 5 mg/ml solution for injection/infusion EU/1/23/1774/001-002 |
Pegzilarginase | Immedica Pharma AB | — |
| RAVICTI 1.1 g/ml oral liquid EU/1/15/1062/001-004 |
Glycerol phenylbutyrate | Immedica Pharma AB | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.